Eric Aguiar - 10 Jun 2026 Form 4 Insider Report for Biomea Fusion, Inc. (BMEA)

Reporting relationship: Director
Issuer ticker: BMEA
Reported as of: 10 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Jun 2026, 16:15:14 UTC
Prior SEC filing: 24 Jun 2025
Next SEC filing: 24 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Rainer Erdtmann as Attorney-in-Fact for Eric Aguiar

Key filing fact

Eric Aguiar filed Form 4 for Biomea Fusion, Inc. (BMEA) on 12 Jun 2026.

Key facts

This page summarizes Eric Aguiar's Form 4 filing for Biomea Fusion, Inc. (BMEA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 12 Jun 2026, 16:15.

Change

Previous filing in this sequence was filed on 24 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001262325 Primary reporting owner

AGUIAR ERIC

Relationship: Director
Address: C/O BIOMEA FUSION, INC., 1599 INDUSTRIAL ROAD, SAN CARLOS
Signature: /s/ Rainer Erdtmann as Attorney-in-Fact for Eric Aguiar
Signature date: 12 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BMEA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +196,299
Change %
Price: $0.000000^*
Shares after: 196,299
Date: 10 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 196,299
Exercise price: $1.15
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.